Synthetic RIG-I-like receptor agonists
Abstract:
The present disclosure relates to, inter alia, RNA molecules (e.g., RNA hairpin agonists) that bind to and agonize RIG-I-like receptors (RLRs), and to use of the molecules in methods for treating, or ameliorating one or more symptoms of, a disorder (e.g., cancer).
Public/Granted literature
Information query
Patent Agency Ranking
0/0